정상 칼시토닌 수치를 보인 갑상선수질암 1례
Medullary Thyroid Carcinoma with Normal Calcitonin Level
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Calcitonin is an important tumor marker for medullary thyroid carcinoma. Serum calcitonin is increased in most cases of medullary thyroid carcinoma. However, medullary thyroid carcinoma with normal calcitonin level has been reported very rarely. 1.2 cm sized solid thyroid nodule was suspicious for medullary thyroid carcinoma in fine needle aspiration cytology, but serum calcitonin was within the normal range. The final pathology after surgery was medullary thyroid carcinoma with positive calcitonin immunohistochemical staining. The authors present a case of calcitonin-negative medullary thyroid cancer with reviews of the mechanism, diagnosis, treatment, prognosis and follow-up of this case.
Abstract
Calcitonin is an important tumor marker for medullary thyroid carcinoma. Serum calcitonin is increased in most cases of medullary thyroid carcinoma. However, medullary thyroid carcinoma with normal calcitonin level has been reported very rarely. 1.2 cm sized solid thyroid nodule was suspicious for medullary thyroid carcinoma in fine needle aspiration cytology, but serum calcitonin was within the normal range. The final pathology after surgery was medullary thyroid carcinoma with positive calcitonin immunohistochemical staining. The authors present a case of calcitonin-negative medullary thyroid cancer with reviews of the mechanism, diagnosis, treatment, prognosis and follow-up of this case.
참고문헌 (16)
- Vardarli I, "Diagnostic accuracy of routine calcitonin measurement for the detection of medullary thyroid carcinoma in the management of patients with nodular thyroid disease : a meta-analysis", Endocr Connect, 10(3), pp.358~370 (2021)
- Trimboli P, "Serum calcitonin negative medullary thyroid carcinoma : a systematic review of the literature", Clin Chem Lab Med, 53(10), pp.1507~1514 (2015)
- Gambardella C, "Calcitonin negative medullary thyroid carcinoma : a challenging diagnosis or a medical dilemma?", BMC Endocr Disord, 19(Suppl 1), pp.45~ (2019)
- Chernyavsky VS, "Calcitonin-negative neuroendocrine tumor of the thyroid : a distinct clinical entity", Thyroid, 21(2), pp.193~196 (2011)
- Cohen R, "Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine(GETC)", J Clin Endocrinol Metab, 85(2), pp.919~922 (2000)
- Yue W, "Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma", Front Endocrinol(Lausanne), 13, pp.1025629~ (2022)
- Kim SJ, "Serum calcitonin-negative medullary thyroid carcinoma : a case series of 19 patients in a single center", Front Endocrinol(Lausanne), 12, pp.747704~ (2021)
- Fangous MS, "The hook effect in calcitonin immunoradiometric assay : a case report", Ann Endocrinol(Paris), 73(6), pp.552~555 (2012)
- Livolsi VA, "Neuroendocrine tumors of the thyroid and their mimics", Endocr Pathol, 32(2), pp.211~221 (2021)
- De Tullio A, "Medullary thyroid cancer with paraganglioma-like pattern diagnosed during pregnancy : a case report and literature revision", Endocr Metab Immune Disord Drug Targets, 20(2), pp.295~302 (2020)
- Frank-Raue K, "Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839patients with sporadic medullary thyroid carcinoma", Thyroid, 23(3), pp.294~300 (2013)
- Costante G, "Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules", J Clin Endocrinol Metab, 92(2), pp.450~455 (2007)
- Wells SA Jr, "Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma", Thyroid, 25(6), pp.567~610 (2015)
- Giovanella L, "Serum calcitonin-negative medullary thyroid carcinoma : role of CgA and CEA as complementary markers", Int J Biol Markers, 23(2), pp.129~131 (2008)
- Brutsaert EF, "Medullary thyroid cancer with undetectable serum calcitonin", J Clin Endocrinol Metab, 100(2), pp.337~341 (2015)
- Baptista PF, "Brain metastasis from calcitonin-negative medullary thyroid carcinoma", Ann Endocrinol(Paris), 83(4), pp.258~260 (2022)